The Fogel Lab, under the direction of the Principal Investigator Dr. Brent Fogel, seeks to understand the basic and fundamental molecular mechanisms underlying human neurodevelopment and neurodegenerative disease. We are currently examining how specific genes and genetic pathways influence the development of two classes of neurogenetic disease: 1) autism spectrum disorder and 2) cerebellar ataxia. Our goal is to better understand the molecular etiologies behind these diseases to improve diagnosis and develop new strategies for better clinical treatments for patients and their families.